US and international PCT Patent-pending No. 63/093,618 was granted 10/19/21 entitled “An Artificial-Intelligence based cognitive system and method for modifying Subconscious Brain Habitualization.”

A teaming agreement and BAA’s were executed with an internal medicine clinical partner for a 2-year T2DM remission product market fit of 60 matched obese, costly T2D members for certified cost savings and outcomes. Our partner participates in a shared savings contract with a 78,000 person Medicare contracted, accountable care organization (ACO) in Palm Beach … Continued

Leveraging IBM Watson Technology to expand our Phase III clinical research for subconscious remodeling, actual cost savings, improved compliance, increased remission, and scale. Our virtual, end-end ecosystem is ready to launch final technology and enrollment steps.